Evidence map›Paper›PMID 40660787›Full record

ArticleMedical physics2025

TrackRAD2025 challenge dataset: real-time tumor tracking for MRI-guided radiotherapy.

Yiling Wang, Elia Lombardo, Adrian Thummerer, Tom Blöcker, Yu Fan, Yue Zhao, Christianna Iris Papadopoulou, Coen Hurkmans, Rob H N Tijssen, Pia A W Görts and 18 more

Abstract read
In one paragraph

Article in Medical physics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

28 authors.

Yiling WangDepartment of Radiation Oncology, Radiation Oncology Key Laboratory of Sichuan Province, Sichuan Clinical Research Center for Cancer, Sichuan Cancer Hospital & Institute, Sichuan Cancer Center, University of Electronic Science and Technology of China, Chengdu, China.
Elia LombardoDepartment of Radiation Oncology, LMU University Hospital, LMU Munich, Munich, Germany.
Adrian ThummererDepartment of Radiation Oncology, LMU University Hospital, LMU Munich, Munich, Germany.
Tom BlöckerDepartment of Radiation Oncology, LMU University Hospital, LMU Munich, Munich, Germany.
Yu FanDepartment of Radiation Oncology, Radiation Oncology Key Laboratory of Sichuan Province, Sichuan Clinical Research Center for Cancer, Sichuan Cancer Hospital & Institute, Sichuan Cancer Center, University of Electronic Science and Technology of China, Chengdu, China.
Yue ZhaoDepartment of Radiation Oncology, Radiation Oncology Key Laboratory of Sichuan Province, Sichuan Clinical Research Center for Cancer, Sichuan Cancer Hospital & Institute, Sichuan Cancer Center, University of Electronic Science and Technology of China, Chengdu, China.
Christianna Iris PapadopoulouDepartment of Radiation Oncology, LMU University Hospital, LMU Munich, Munich, Germany.
Coen HurkmansDepartment of Radiation Oncology, Catharina Hospital, Eindhoven, The Netherlands.
Rob H N TijssenDepartment of Radiation Oncology, Catharina Hospital, Eindhoven, The Netherlands.
Pia A W GörtsDepartment of Radiation Oncology, Catharina Hospital, Eindhoven, The Netherlands.
Shyama U TetarDepartment of Radiation Oncology, Catharina Hospital, Eindhoven, The Netherlands.
Davide CusumanoMedical Physics Unit, Mater Olbia Hospital, Olbia, Italy.
Martijn Pw IntvenDepartment of Radiotherapy, University Medical Center Utrecht, Utrecht, The Netherlands.
Pim BormanDepartment of Radiotherapy, University Medical Center Utrecht, Utrecht, The Netherlands.
Marco RiboldiDepartment of Medical Physics, Ludwig-Maximilians-Universität München, Garching, Germany.
Denis DudášFaculty of Nuclear Sciences and Physical Engineering, Czech Technical University in Prague, Prague, Czech Republic.
Hilary ByrneFaculty of Medicine and Health, Image X Institute, University of Sydney, Darlington, New South Wales, Australia.
Lorenzo PlacidiFondazione Policlinico Universitario Agostino Gemelli, IRCCS, Department of Diagnostic Imaging, Oncological Radiotherapy and Hematology, Rome, Italy.
Marco FusellaDepartment of Radiation Oncology, Abano Terme Hospital, Abano Terme, Veneto, Italy.
Michael JamesonGenesisCare, St Vincent's Hospital, Sydney, Australia.
Miguel PalaciosDepartment of Radiation Oncology, Amsterdam UMC location Vrije Universiteit Amsterdam, Amsterdam, The Netherlands.
Paul CobussenDepartment of Radiation Oncology, Amsterdam UMC location Vrije Universiteit Amsterdam, Amsterdam, The Netherlands.
Tobias FinazziDepartment of Radiation Oncology, Amsterdam UMC location Vrije Universiteit Amsterdam, Amsterdam, The Netherlands.
Cornelis J A HaasbeekDepartment of Radiation Oncology, Amsterdam UMC location Vrije Universiteit Amsterdam, Amsterdam, The Netherlands.
Paul KeallImage X Institute, Faculty of Medicine and Health, University of Sydney, Sydney, Australia.
Christopher KurzDepartment of Radiation Oncology, LMU University Hospital, LMU Munich, Munich, Germany.
Guillaume LandryDepartment of Radiation Oncology, LMU University Hospital, LMU Munich, Munich, Germany.
Matteo MasperoDepartment of Radiotherapy, University Medical Center Utrecht, Utrecht, The Netherlands.

Funding

Sichuan Science and Technology Program 2023YFH0079
6 · The paper itself

Abstract

purposeMagnetic resonance imaging (MRI) to visualize anatomical motion is becoming increasingly important when treating cancer patients with radiotherapy. Hybrid MRI-linear accelerator (MRI-linac) systems allow real-time motion management during irradiation. This paper presents a multi-institutional real-time MRI time series dataset from different MRI-linac vendors. The dataset is designed to support developing and evaluating real-time tumor localization (tracking) algorithms for MRI-guided radiotherapy within the TrackRAD2025 challenge ( https://trackrad2025.grand-challenge.org/). ACQUISITION AND VALIDATION

methodsThe dataset consists of sagittal 2D cine MRIs (20-20543 frames per scan) in 585 patients from six centers (3 Dutch, 1 German, 1 Australian, and 1 Chinese). Tumors in the thorax, abdomen, and pelvis acquired on two commercially available MRI-linacs (0.35 T and 1.5 T) were included. For 108 cases, irradiation targets or tracking surrogates were manually segmented on each temporal frame. The dataset was randomly split into a public training set of 527 cases (477 unlabeled and 50 labeled) and a private testing set of 58 cases (all labeled). DATA FORMAT AND USAGE NOTES: The data is publicly available under the TrackRAD2025 collection: https://doi.org/10.57967/hf/4539. Both the images and segmentations for each patient are available in metadata format. POTENTIAL APPLICATIONS: This novel clinical dataset will enable the development and evaluation of real-time tumor localization algorithms for MRI-guided radiotherapy. By enabling more accurate motion management and adaptive treatment strategies, this dataset has the potential to advance the field of radiotherapy significantly.

Indexed as

Databases, FactualMagnetic Resonance ImagingNeoplasmsRadiotherapy, Image-GuidedHumansImage Processing, Computer-AssistedTime FactorsMRI‐guided radiotherapyReal‐time tumor localizationTrackRAD2025

Identifiers

PMID40660787
PMCPMC12260481

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.